KBTBD4 and medulloblastoma: We reasoned that the D283Med cell line represented a particularly suitable model to investigate the role of KBTBD4 mutations in medulloblastoma as, in terms of transcriptional identity, D283Med are close to the identified subtype II of a more recent medulloblastoma classification of group 3 and 4 subtypes [17].